Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Ugurel-Becker Selma |

Präsentationen bei wissenschaftlichen Veranstaltungen

Ugurel, S; Loquai, C; Terheyden, P; Schadendorf, D; Richtig, E; Utikal, J; Gutzmer, R; Rass, K; Sunderkotter, C; Stein, A; Fluck, M; Kaatz, M; Trefzer, U; Hauschild, A; Stadler, R; Berking, C; Pehamberger, H; Kopp-Schneider, A; Becker, JC Ex-vivo sensitivity-directed combination chemotherapy compared to DTIC monochemotherapy in chemo-naive advanced metastastic melanoma (ChemoSensMM): a multicenter randomized phase-3 DeCOG trial
J DTSCH DERMATOL GES. 2015; 13: 18-19.-25. Deutscher Hautkrebskongress; Sept 10-12, 2015; München. [Oral Communication]
Web of Science

 

Schrama, D; Groesser, L; Haffner, C; Ugurel, S; Pastrana, D; Buck, C; Cerroni, L; Theiler, A; Becker, JC Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor induced epithelial proliferations
J DTSCH DERMATOL GES. 2014; 12: 42-42.-Deutscher Hautkrebskongress und ADO-Jahrestagung; SEP 11-13 2014; Frankfurt am Main, GERMANY. [Poster]
Web of Science

 

Becker, J; Pflugfelder, A; Trefzer, U; Ugurel, S; Pfohler, C; Kellner, Y; Beissert, S; Kahler, K; Mohr, P; Zouboulis, C; Zimmer, L; Belloni, B; Berking, C; Schadendorf, D; Merkel Cell Carcinoma Register of the ADO - the first Evaluation.
J DTSCH DERMATOL GES. 2013; 11(9):909-910.-Deutscher Hautkrebskongress; September, 2013; Essen, D. [Oral Communication]
Web of Science

 

Schrama, D; Ugurel, S; Schadendorf, D; Becker, JC; No association of STAT3 rs4796793 SNP with response to IFN alpha therapy in patients with metastatic melanoma.
EXP DERMATOL. 2013; 22(3):E22-E22.-40th Annual Meeting of the Association-of-Dermatological-Research; MAR 14-16, 2013; Dessau, GERMANY. [Poster]
Web of Science

 

Ugurel, S; Mentzel, T; Utikal, J; Helmbold, P; Mohr, P; Pfohler, C; Schiller, M; Hauschild, A; Hein, R; Kampgen, E; Kellner, I; Leverkus, M; Becker, J; Strobel, P; Schadendorf, D. Neo-adjuvant Therapy of Dermatofibrosarcoma protuberans with Imatinib: A multicenter Phase II Study of the ADO.
J DTSCH DERMATOL GES. 2013; 11(9):909-909.-ADO-Tagung; September, 2013; Essen, D. [Oral Communication]
Web of Science

 

Aigner, B; Richtig, E; Becker, J; Marterer, R; Niederkom, A; Lingitz, H; Ugurel, S; Partial Remission of metastatic Mucosal melanoma receiving palliative therapy with Trofosfamide.
J DTSCH DERMATOL GES. 2012; 10(9):695-695.-ADO; Hannover. [Poster]
Web of Science

 

Livingstone, E; Eigentler, T; Windemuth-Kieselbach, C; Rompel, R; Trefzer, U; Nashan, D; Ugurel, S; Gesierich, A; Kahler, K; Schadendorf, D; Quality Assurance Project melanoma: Results of the Interim Survey 2 years after Initial diagnosis.
J DTSCH DERMATOL GES. . 2012; 10(9):678-678. [Poster]
Web of Science

 

Aigner, BA; Richtig, E; Becker, JC; Ugurel, S Partielle Remission eines ausgedehnt fernmetastasierten Schleimhautmelanoms unter palliativer oraler Chemotherapie mit Trofosfamid
Abstractband der ÖGDV 2011. 2011; -Jahrestagung der ÖGDV in Linz; NOV 11-13, 2011; Linz, AUSTIRA. [Poster]

 

Degen, A; Weichenthal, M; Ugurel, S; Trefzer, U; Gauwerky, K; Garbe, C; Egberts, F; Frey, L; Hauschild, A; Gutzmer, R Cutaneous Side Effects of combination Therapy with Sorafenib and Peginterferon - an Evaluation of the SoraPeg Study of the ADO
J DTSCH DERMATOL GES. . 2011; 9(9):779-779.-21. Deutscher Hautkrebs-Kongress 2011 und ADO Jahrestagung; SEP 15-17, 2011; Weimar, GERMANY. [Poster]
Web of Science

 

Heinemann, A; Sucker, A; Steinle, A; Eberle, J; Ugurel, S; Schadendorf, D; Paschen, A Connecting expression of the immunological cell stress indicator ULBP2 to the tumor suppressor activity of p53
EXP DERMATOL. . 2011; 20(2):P117--38th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF); FEB 17-19, 2011; Tuebingen, GERMANY. [Poster]
Web of Science

 

Justich, A; Niederkorn, A; Tilz, H; Massone, C; Richtig, E; Becker, J; Ugurel, S Regression of a case of complete Paraplegia due to multiple Vertebral Body Metastases of a Melanoma being treated by BRAF-Inhibitor Vemurafenib
J DTSCH DERMATOL GES. 2011; 9(9):786-786.-21. Jahrestagung der ADO; Sept 15-17, 2011; Weimar, Deutschland. [Poster]
Web of Science

 

Niederkorn, A; Tilz, HE; Justich, A; Richtig, E; Ugurel, S; Becker, J Response of an inoperative Relapse of a primary cutaneous large B-Cell-Lymphoma with endonasal Infiltration during Chemotherapy with pegylated liposomal Doxorubicine in Combination with Rituximab.
J DTSCH DERMATOL GES. 2011; 9(9):787-787.-21. Jahrestagung der ADO; Sept 15-17, 2011; Weimar, Deutschland. [Poster]
Web of Science

 

Richtig, E; Ugurel, S; Niederkorn, A; Justich, A; Tilz, H; Becker, J Onset and rapid Progression of Vitiligo in a Patient with metastatic malignant Melanoma under Ipilimumag Therapy - possibly triggered by an increase in ACTH Process?
J DTSCH DERMATOL GES. 2011; 9(9):784-784.-21. Jahrestagung der ADO; Sept 15-17, 2011; Weimar, Deutschland. [Poster]
Web of Science

 

Richtig, E; Ugurel, S; Niederkorn, A; Justich, A; Tilz, H; Becker, J Increase of Pancreatic Enzymes and of the Cortisol Levels in Patients with metastatic Melanoma under a Therapy with Ipilimumab
J DTSCH DERMATOL GES. 2011; 9(9):784-784.-21. Jahrestagung der ADO; Sept 15-17, 2011; Weimar, Deutschland. [Poster]
Web of Science

 

Tilz, H; Inzinger, M; Richtig, E; Massone, C; Ugurel, S; Niederkorn, A; Aigner, BA, Becker, JC Pulmonale Sarkoidose nach adjuvanter Interferontherapie eines malignen Melanoms
Abstractband der ÖGDV 2011. 2011; -Jahrestagung der ÖGDV in Linz; NOV 11-13, 2011; Linz, AUSTRIA. [Poster]

 

Tilz, HE; Niederkorn, A; Justich, A; Prettenhofer, U; Massone, C; Richtig, E; Becker, J; Ugurel, S Successful Therapy of a Stewart Treves Angio Sarcoma by way of Radiation and Paclitaxel
J DTSCH DERMATOL GES. 2011; 9(9):789-789. [Poster]
Web of Science

 

Heinemann, A; Sucker, A; Moll, I; Steinle, A; Schadendorf, D; Becker, J; Ugurel, S; Paschen, A The Role of ULBP2 in Melanoma: Clinical Significance and Regulation.
J DTSCH DERMATOL GES. 2010; 8(9):749-749.-20. Deutscher Hautkrebskongress und ADO Jahrestagung ; Sep 23-25, 2010; Kiel, Germany . [Poster]
Web of Science

 

Willmes, C; Kumar, R; Becker, JC; Schrama, D; Ugurel, S Identification of SerpinB1 as a novel predictive molecular marker for chemosensitivity in melanoma
link auf der ADF Homepage. 2010; -37th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF); Feb 18-20; Lübeck, GERMANY. [Poster]
FullText

 

Baumann, R; Ritter, C; Menaa, F; Houben, R; Synwoldt, P; Wischhusen, J; Schrama, D; Ugurel, S; Becker, JC Melanoma cells with characteristic of cancer stem cells
Journal der Deutschen Dermatologischen Gesellschaft. 2009; 7(9):825-854.-5. Deutscher Hautkrebskongress und 19. Jahrestagung der Arbeitsgemeinschaft Dermatologische Onkologie (ADO) ; Sep 24-26; Köln, GERMANY. [Poster]

 

Schrama, D; Scherer, D; Schneider, M; Zapatka, M; Ugurel, S; Kumar, R; Becker, JC XPG D1104H and XPD K751Q polymorphisms are independent prognostic factors for melanoma
link auf der Homepage der ADF2009; -36th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF); Mar 5-7, 2009; Heidelberg, GERMANY. [Poster]
FullText

 

Willmes, C; Kumar, R; Becker, JC; Schrama, D; Ugurel, S Identifikation von prädiktiven Biomarkern der ex-vivo Chemosensitivität und des klinischen Chemotherapieerfolgs beim malignen Melanom.
Journal der deutschen dermatologischen Gesellschaft DOI: 10.1111/j.1610-0387.2009.07201.x. 2009; 7(9):825-854.-5. Deutscher Hautkrebskongress und 19. Jahrestagung der Arbeitsgemeinschaft Dermatologische Onkologie (ADO); SEP 24-26; Köln, GERMANY. [Oral Communication]

 

© Meduni Graz Impressum